Compounds > eicosapentaenoic acid ethyl ester

eicosapentaenoic acid ethyl ester and iloprost

eicosapentaenoic acid ethyl ester has been researched along with iloprost in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abosheasha, MA; El-Gowily, AH	1

Other Studies

1 other study(ies) available for eicosapentaenoic acid ethyl ester and iloprost

Article	Year
Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 M Drug development research, 2021, Volume: 82, Issue:2 Topics: Cilostazol; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Eicosapentaenoic Acid; Epoprostenol; Humans; Iloprost; Molecular Docking Simulation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; SARS-CoV-2; Spike Glycoprotein, Coronavirus; United States; United States Food and Drug Administration	2021

Article

Year

Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 M

Drug development research, 2021, Volume: 82, Issue:2

Topics: Cilostazol; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Eicosapentaenoic Acid; Epoprostenol; Humans; Iloprost; Molecular Docking Simulation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; SARS-CoV-2; Spike Glycoprotein, Coronavirus; United States; United States Food and Drug Administration

2021